Research map: Induction of cuproptosis via targeting mitochondrial metabolism using dPTBD with potent therapeutic activity against KRAS-driven cancer

Back to the article

Papers in this map

  1. Copper induces cell death by targeting lipoylated TCA cycle proteins · Peter Tsvetkov · 2022 · 5027 citations · Cited by this paper
  2. Commentary regarding “Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study” · 2026 · Related
  3. [1] Role of free radicals and catalytic metal ions in human disease: An overview · Barry B. Halliwell · 1990 · 5019 citations · Cited by this paper
  4. Optimized L1CAM-CAR T cells enhance activity against moderate-antigen-density rhabdomyosarcoma models · 2026 · Related
  5. A Comprehensive Survey of Ras Mutations in Cancer · Ian Andrew Prior · 2012 · 2110 citations · Cited by this paper
  6. VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3+ macrophages and enhancing antitumor immunity · 2026 · Related
  7. Sotorasib for Lung Cancers with KRAS p.G12C Mutation · Ferdinandos Skoulidis · 2021 · 1874 citations · Cited by this paper
  8. GSN liquid-liquid phase separation induces PANoptosis by inhibiting YAP-dependent glycolysis to alleviate the progression of clear cell renal cell carcinoma · 2026 · Related
  9. Tumor glycolysis as a target for cancer therapy: progress and prospects · Shanmugasundaram Ganapathy‐Kanniappan · 2013 · 1494 citations · Cited by this paper
  10. Mechano-activation of osteocytic connexin hemichannels prime microenvironment in suppressing breast cancer bone metastasis · 2026 · Related
  11. Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation · Pasi Antero Janne · 2022 · 1052 citations · Cited by this paper
  12. The m6A epitranscriptome in cancer therapy resistance: From cellular plasticity and metabolic rewiring to immune escape and therapeutic targeting · 2026 · Related
  13. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease · Marián Valko · 2015 · 1033 citations · Cited by this paper
  14. Elevated FN14 expression promotes proliferation, chemoresistance, and impairment of differentiation in rhabdomyosarcoma · 2026 · Related
  15. PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis · Weiwei Yang · 2012 · 864 citations · Cited by this paper
  16. Targeting MDA-9/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells · 2026 · Related
  17. Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor · Xiaolun Wang · 2021 · 756 citations · Cited by this paper
  18. Antibody-drug conjugates against multidrug-resistant cancers: Biomarker-guided patient selection, payload engineering, linker chemistry, and bystander effects · 2026 · Related
  19. Targeting ROS in cancer: rationale and strategies · Christophe Glorieux · 2024 · 647 citations · Cited by this paper
  20. Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer · 2026 · Related
  21. The current state of the art and future trends in RAS-targeted cancer therapies · Salman Rafi Punekar · 2022 · 545 citations · Cited by this paper
  22. Pan-KRAS inhibitor disables oncogenic signalling and tumour growth · Dong-Sung Kim · 2023 · 540 citations · Cited by this paper
  23. Targeting cuproplasia and cuproptosis in cancer · Daolin Tang · 2024 · 440 citations · Cited by this paper
  24. Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion · Florida Voli · 2020 · 436 citations · Cited by this paper
  25. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma · Kewen Hu · 2019 · 411 citations · Cited by this paper
  26. Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma · Steven J O'Day · 2013 · 404 citations · Cited by this paper
  27. Targeting KRAS in cancer · Anupriya Singhal · 2024 · 330 citations · Cited by this paper
  28. A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling · Michelle L. Turski · 2012 · 325 citations · Cited by this paper
  29. Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer · Léo Aubert · 2020 · 321 citations · Cited by this paper
  30. K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis · Yumin Hu · 2011 · 307 citations · Cited by this paper
  31. Mitochondrial copper metabolism and delivery to cytochrome c oxidase · Darryl M. Horn · 2008 · 278 citations · Cited by this paper
  32. Zinc, Copper, and Magnesium and Risks for All-Cause, Cancer, and Cardiovascular Mortality · Nathalie Léone · 2006 · 271 citations · Cited by this paper
  33. Serum and Tissue Trace Elements in Patients with Breast Cancer in Taiwan · Hsien‐Wen Kuo · 2002 · 269 citations · Cited by this paper
  34. Anticancer Activity of the Antibiotic Clioquinol · Wei‐Qun Ding · 2005 · 254 citations · Cited by this paper
  35. Menkes' Kinky Hair Disease: Further Definition of the Defect in Copper Transport · David M. Danks · 1973 · 219 citations · Cited by this paper
  36. A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer · Hovav Nechushtan · 2015 · 208 citations · Cited by this paper
  37. Initial Therapy of Patients With Wilson's Disease With Tetrathiomolybdate · George J. Brewer · 1991 · 192 citations · Cited by this paper
  38. Regulation and function of pyruvate kinase M2 in cancer · Weiwei Yang · 2013 · 183 citations · Cited by this paper
  39. Integrated Approach for Manual Evaluation of Peptides Identified by Searching Protein Sequence Databases with Tandem Mass Spectra · Yue Chen · 2005 · 177 citations · Cited by this paper

Source: OpenAlex (CC0)